Andon Health Soars 10% to Day High of CNY 58.52 Amid Strong Intraday Performance

Andon Health Co., Ltd. has experienced a significant surge in its stock price, gaining 10.0% on March 11, 2026. The stock reached an intraday high of CNY 58.52, showcasing notable activity in the pharmaceuticals and biotechnology sector. In terms of performance metrics, Andon Health's one-day performance stands out against the China Shanghai Composite, which only increased by 0.25%. Over the past week, the stock has risen by 14.77%, and its one-month performance reflects a remarkable 39.9% increase. Year-to-date, Andon Health has achieved a 46.15% gain, significantly outperforming the broader market index. Despite these positive short-term trends, the company has faced challenges in its financial results, including a substantial decline in operating profit and negative net profit growth over recent quarters. The market capitalization of Andon Health is currently CNY 18,799 million, with a price-to-earnings ratio of 25.00 and a dividend yield of 0.49%. As the company navigates its financial landscape, its recent stock performance highlights the dynamic nature of the market.